EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Suppressor of Cytokine Signaling 1 Haploinsufficiency

Meng Liu, Evan Hsu, Yan Du, Pui Y Lee

Rheumatic Disease Clinics of North America · 2023

DOI: 10.1016/j.rdc.2023.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2023. Verfasst von Meng Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Rheumatology and Immunology, Guangdong …. Hauptthemen laut MEDLINE: Autoimmunity, Haploinsufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Suppressor of cytokine signaling 1 (SOCS1) is a negative regulator of cytokine signaling that inhibits the activation of Janus kinases. A human disease caused by SOCS1 haploinsufficiency was first identified in 2020. To date, 18 cases of SOCS1 haploinsufficiency have been described. These patients experience enhanced activation of leukocytes and multiorgan system immunodysregulation, with immune-mediated cytopenia as the most common feature. In this review, the authors provide an overview on the biology of SOCS1 and summarize their knowledge of SOCS1 haploinsufficiency including genetics and clinical manifestations. They discuss the available treatment experience and outline an approach for the evaluation of suspected cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityHaploinsufficiencyHumansSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling ProteinsCytokines

Stichwörter der Autor:innen

Autoimmune diseaseAutoimmunitySOCS1SOCS1 haploinsufficiency

Substanzen

Suppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling ProteinsCytokines

Autor:innen und Institutionen

  • Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China.
  • Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, C…
  • Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: pui.lee@childrens.harvard.edu.

Zitieren

APA

Liu, M., Hsu, E., Du, Y., & Lee, P. Y. (2023). Suppressor of Cytokine Signaling 1 Haploinsufficiency. Rheumatic Disease Clinics of North America. https://doi.org/10.1016/j.rdc.2023.06.003

Vancouver

Liu M, Hsu E, Du Y, Lee PY. Suppressor of Cytokine Signaling 1 Haploinsufficiency. Rheumatic Disease Clinics of North America. 2023. doi:10.1016/j.rdc.2023.06.003

BibTeX
@article{Liu2023,
  author = {Liu, Meng and Hsu, Evan and Du, Yan and Lee, Pui Y},
  title = {Suppressor of Cytokine Signaling 1 Haploinsufficiency},
  journal = {Rheumatic Disease Clinics of North America},
  year = {2023},
  doi = {10.1016/j.rdc.2023.06.003}
}
Kostenlos starten →